The Function of Dendritic Cells Derived from Chronic Myeloid Leukemia
- Author:
Liming WANG
1
;
Shanshan CHEN
;
Yanrong LIU
;
Jiayu FU
;
Hong YU
;
Jinlan LI
;
Zikuan GUO
Author Information
1. Institute of Hematology, Beijing Medical Univercity, Beijing 100044, China.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2000;8(3):161-165
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of this study was to investigate the function of dendritic cells derived from chronic myeloid leukemia (CML-DC). Mononuclear cells were prepared from bone marrow and peripheral blood of 24 patients with CML, and the DCs were obtained by incubation of MNCs with media containing GM-CSF, IL-4 and TNF-alpha. The phenotype of CML-DCs was identified by flow cytometry. FITC-dextran uptake, (3)H-TdR incorporation or MTT assay and lactate dehydrogenase release assay were used to detect uptake of exogenous antigen in immature DCs, the antigen presenting ability in mature DCs and specific cytotoxicity of CTL to leukemic cells, respectively. The DCs with high expression of CD1a, CD86, CD80, HLA-DR, CD54 and CD4 were obtained from marrow and blood of patients with CML. The uptake of FITC-DX was observed in early DCs. There was a potent stimulation to allo-MLR in DCs cultured for 7 - 10 days, and a lightly lower stimulation to auto-MLR. CML-DCs can induce the generation of specific cytotoxic T cells. These results suggest that CML-DCs are functional DCs with the ability to induce anti-leukemia effect.
